학술논문
Cabozantinib plus atezolizumab versus sorafenib for advanced hepatocellular carcinoma (COSMIC-312): final results of a randomised phase 3 study
Document Type
Article
Author
Source
In: The Lancet Gastroenterology and Hepatology . (The Lancet Gastroenterology and Hepatology, April 2024, 9(4):310-322)
Subject
Language
English
ISSN
24681253